Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Other Current Liabilities: د.إ7 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADX:JULPHAR Gulf Pharmaceutical Industries PSC ADX:JULPHAR
65 GF Score
Price د.إ1.06
GF Value د.إ1.11
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Gulf Pharmaceutical Industries PSC Other Current Liabilities?

Gulf Pharmaceutical Industries PSC ADX:JULPHAR 65 Other Current Liabilities is د.إ7 Mil as of Jun. 2026. GuruFocus rates ADX:JULPHAR with a GF Score™ of 65/100 and a GF Value™ of د.إ1.11 (Fairly Valued). The stock has 5 warning signs investors should review.

Gulf Pharmaceutical Industries PSC's other current liabilities for the quarter that ended in Jun. 2026 was د.إ7 Mil.

Gulf Pharmaceutical Industries PSC's quarterly other current liabilities declined from Dec. 2025 (د.إ170 Mil) to Mar. 2026 (د.إ110 Mil) and declined from Mar. 2026 (د.إ110 Mil) to Jun. 2026 (د.إ7 Mil).

Gulf Pharmaceutical Industries PSC's annual other current liabilities increased from Dec. 2023 (د.إ87 Mil) to Dec. 2024 (د.إ249 Mil) but then declined from Dec. 2024 (د.إ249 Mil) to Dec. 2025 (د.إ170 Mil).

Gulf Pharmaceutical Industries PSC Other Current Liabilities Related Terms

Gulf Pharmaceutical Industries PSC Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Gulf Pharmaceutical Industries PSC's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gulf Pharmaceutical Industries PSC Other Current Liabilities Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 122.40 87.40 86.60 248.70 170.20

Gulf Pharmaceutical Industries PSC Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 138.30 170.20 109.90 6.80
ADX:JULPHAR
65GF Score
Gulf Pharmaceutical Industries PSC ADX:JULPHAR
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gulf Pharmaceutical Industries PSC Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of د.إ7 Mil mean?
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) has a Other Current Liabilities of د.إ7 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gulf Pharmaceutical Industries PSC.
Is Gulf Pharmaceutical Industries PSC's Other Current Liabilities too high?
Gulf Pharmaceutical Industries PSC's current Other Current Liabilities is د.إ7 Mil. Overall, Gulf Pharmaceutical Industries PSC has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gulf Pharmaceutical Industries PSC's Other Current Liabilities compare to MCK and COR?
Gulf Pharmaceutical Industries PSC's Other Current Liabilities of د.إ7 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Distribution company?
A good Other Current Liabilities depends on the Medical Distribution industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gulf Pharmaceutical Industries PSC. Gulf Pharmaceutical Industries PSC's current Other Current Liabilities is د.إ7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Pharmaceutical Industries PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) is currently considered Fairly Valued. The stock's GF Value™ is د.إ1.11, compared to a current price of د.إ1.06 — trading 4.5% below its estimated fair value. The current Other Current Liabilities is د.إ7 Mil. Gulf Pharmaceutical Industries PSC's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Gulf Pharmaceutical Industries PSC (ADX:JULPHAR), the current Other Current Liabilities is د.إ7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued. The current stock price of د.إ1.06 is trading 4.5% below its estimated GF Value™ of د.إ1.11. GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.

Key valuation signals for ADX:JULPHAR:

  • Other Current Liabilities: د.إ7 Mil
  • GF Value™: د.إ1.11 vs. price of د.إ1.06 (4.5% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gulf Pharmaceutical Industries PSC Business Description

Address Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
65GF Score

Get the complete analysis for ADX:JULPHAR

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

د.إ1.06
Price
د.إ1.11
GF Value